rs12117237
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The ENST00000337393.10(ZNF644):āc.2119A>Gā(p.Lys707Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00412 in 1,614,010 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
ENST00000337393.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF644 | NM_201269.3 | c.2119A>G | p.Lys707Glu | missense_variant | 3/6 | ENST00000337393.10 | NP_958357.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF644 | ENST00000337393.10 | c.2119A>G | p.Lys707Glu | missense_variant | 3/6 | 1 | NM_201269.3 | ENSP00000337008 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00323 AC: 491AN: 152122Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00364 AC: 912AN: 250860Hom.: 2 AF XY: 0.00375 AC XY: 509AN XY: 135734
GnomAD4 exome AF: 0.00421 AC: 6157AN: 1461770Hom.: 20 Cov.: 34 AF XY: 0.00419 AC XY: 3048AN XY: 727180
GnomAD4 genome AF: 0.00323 AC: 492AN: 152240Hom.: 1 Cov.: 32 AF XY: 0.00359 AC XY: 267AN XY: 74450
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 16, 2018 | - - |
ZNF644-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 12, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at